Literature DB >> 20979532

The mouse alpha-albumin (afamin) promoter is differentially regulated by hepatocyte nuclear factor 1α and hepatocyte nuclear factor 1β.

Hua Liu1, Hui Ren, Brett T Spear.   

Abstract

Alpha-albumin (AFM), a member of the albumin gene family that also includes albumin, alpha-fetoprotein, and vitamin D-binding protein, is expressed predominantly in the liver and activated at birth. Here, we identify two hepatocyte nuclear factor 1 (HNF1)-binding sites in the AFM promoter that are highly conserved in different mammals. These two sites bind HNF1α and HNF1β. The distal site (centered at -132, relative to AFM exon 1) is more important than proximal site (centered at -58), based on HNF1 binding and mutational analysis in transfected cells. Our data indicate that HNF1α is a more potent activator of AFM promoter than is HNF1β. However, HNF1β can act in a dominant manner to inhibit HNF1α-dependent transactivation of the AFM promoter when both proteins are expressed together. This suggests that the differential timing with which the albumin family genes are activated in the liver may be influenced by their responsiveness to HNF1α and HNF1β. Our comparison of HNF1-binding sites in the promoters in the albumin family of genes indicates that the primordial albumin-like gene contained two HNF1 sites; one of these sites was lost from the albumin promoter, but both sites still are present in other members of this gene family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979532      PMCID: PMC3045788          DOI: 10.1089/dna.2010.1097

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  39 in total

Review 1.  Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression.

Authors:  Harald Schrem; Jürgen Klempnauer; Jürgen Borlak
Journal:  Pharmacol Rev       Date:  2002-03       Impact factor: 25.468

2.  Activation of nuclear factor-kappaB by the peroxisome proliferator ciprofibrate in H4IIEC3 rat hepatoma cells and its inhibition by the antioxidants N-acetylcysteine and vitamin E.

Authors:  Y Li; H P Glauert; B T Spear
Journal:  Biochem Pharmacol       Date:  2000-02-15       Impact factor: 5.858

3.  Role of hepatocyte nuclear factor 1alpha and 1beta in the transcriptional regulation of human dipeptidyl peptidase IV during differentiation of Caco-2 cells.

Authors:  R H Erickson; R S Lai; Y S Kim
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

4.  Significant down-regulation of alpha-albumin in human hepatoma and its implication.

Authors:  G X Wu; Y M Lin; T H Zhou; H Gao; G Pei
Journal:  Cancer Lett       Date:  2000-11-28       Impact factor: 8.679

5.  The molecular clock runs at different rates among closely related members of a gene family.

Authors:  P E Gibbs; W F Witke; A Dugaiczyk
Journal:  J Mol Evol       Date:  1998-05       Impact factor: 2.395

6.  Chicken ovalbumin upstream promoter-transcription factor, hepatocyte nuclear factor 3, and CCAAT/enhancer binding protein control the far-upstream enhancer of the rat alpha-fetoprotein gene.

Authors:  H Thomassin; B Bois-Joyeux; R Delille; R Ikonomova; J L Danan
Journal:  DNA Cell Biol       Date:  1996-12       Impact factor: 3.311

Review 7.  Mammalian phylogenomics comes of age.

Authors:  William J Murphy; Pavel A Pevzner; Stephen J O'Brien
Journal:  Trends Genet       Date:  2004-12       Impact factor: 11.639

8.  The alpha-fetoprotein enhancer region activates the albumin and alpha-fetoprotein promoters during liver development.

Authors:  Lin Jin; Lingyun Long; Michael A Green; Brett T Spear
Journal:  Dev Biol       Date:  2009-09-24       Impact factor: 3.582

9.  An intronic locus control region plays an essential role in the establishment of an autonomous hepatic chromatin domain for the human vitamin D-binding protein gene.

Authors:  Tomoko Hiroki; Stephen A Liebhaber; Nancy E Cooke
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

10.  Alpha-fetoprotein related gene (ARG): a new member of the albumin gene family that is no longer functional in primates.

Authors:  Sathyabama Naidu; Martha L Peterson; Brett T Spear
Journal:  Gene       Date:  2009-09-03       Impact factor: 3.688

View more
  7 in total

Review 1.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.

Authors:  Martha L Peterson; Chunhong Ma; Brett T Spear
Journal:  Semin Cancer Biol       Date:  2011-01-07       Impact factor: 15.707

2.  Pericentral activity of alpha-fetoprotein enhancer 3 and glutamine synthetase upstream enhancer in the adult liver are regulated by β-catenin in mice.

Authors:  Erica L Clinkenbeard; James E Butler; Brett T Spear
Journal:  Hepatology       Date:  2012-11       Impact factor: 17.425

Review 3.  New insights into the role of HNF-1β in kidney (patho)physiology.

Authors:  Silvia Ferrè; Peter Igarashi
Journal:  Pediatr Nephrol       Date:  2018-07-01       Impact factor: 3.714

4.  Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.

Authors:  Rabea A Hall; Roman Liebe; Katrin Hochrath; Andrey Kazakov; Rudi Alberts; Ulrich Laufs; Michael Böhm; Hans-Peter Fischer; Robert W Williams; Klaus Schughart; Susanne N Weber; Frank Lammert
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

5.  Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.

Authors:  Liang Duan; Yan Yan; Jingyi Liu; Bo Wang; Pu Li; Qin Hu; Weixian Chen
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

6.  Development of a Lac Operon Concept Inventory (LOCI).

Authors:  Katherine M Stefanski; Grant E Gardner; Rebecca L Seipelt-Thiemann
Journal:  CBE Life Sci Educ       Date:  2016       Impact factor: 3.325

7.  Serum Afamin a Novel Marker of Increased Hepatic Lipid Content.

Authors:  Timea Kurdiova; Miroslav Balaz; Zuzana Kovanicova; Erika Zemkova; Martin Kuzma; Vitazoslav Belan; Juraj Payer; Daniela Gasperikova; Hans Dieplinger; Barbara Ukropcova; Jozef Ukropec
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.